New Jersey A 3359: Prohibits sex offenders from holding any job, position, or type of employment that primarily consists of contact with children.

Bill Text

A3359 

ASSEMBLY, No. 3359 

STATE OF NEW JERSEY

222nd LEGISLATURE

� 

PRE-FILED FOR INTRODUCTION IN THE 2026 SESSION

Sponsored by:

Assemblyman STERLEY S. STANLEY

District 18 (Middlesex)

Assemblyman WILLIAM B. SAMPSON, IV

District 31 (Hudson)

Co-Sponsored by:

Assemblywomen Speight and Murphy

SYNOPSIS

���� Regulates provision of pharmaceutical services in 
nursing homes.

CURRENT VERSION OF TEXT 

���� Introduced Pending Technical Review by Legislative 
Counsel.

��

An Act 
concerning nursing homes and 
pharmaceutical services and supplementing Title 26 of the Revised Statutes

���� Be It 
Enacted by the Senate and General Assembly of 
the State of New Jersey:

���� 1.� a.� As used in this act:

���� "Consultant 
pharmacist" means a pharmacist licensed by the New Jersey State Board of 
Pharmacy, who meets the qualifications provided in N.J.A.C.10:51-3.3 or its 
successor regulation.

���� �Long-term care facility� 
means a nursing home licensed pursuant to P.L.1971, c.136 (C.26:2H-1 et seq.).

���� �Pharmacist� means a 
pharmacist licensed pursuant to P.L.2003, c.280 (C.45:14-40 et seq.)

���� b.� Each long-term care 
facility shall have a consultant pharmacist and either a provider pharmacist 
or, if the facility has an in-house pharmacy, a director of pharmaceutical 
services.� 

���� c.� A New Jersey licensed 
pharmacist shall serve as director of pharmaceutical services or as consultant 
pharmacist.� The pharmacist shall comply with federal and State statutes, 
rules, regulations, and currently accepted standards of practice.

���� d.� Each long-term care 
facility shall have an interdisciplinary pharmacy and therapeutics committee, 
appointed by and reporting to the facility�s administrator and consisting of at 
least the administrator, a representative of the nursing staff, and the facility�s 
consultant pharmacist, with oversight as needed by the facility�s medical 
director.� The committee may include a licensed pharmacist representing the 
provider pharmacy.� The committee shall hold meetings at least quarterly.� 
Records, including the dates of meetings, attendance, activities, findings, and 
recommendations, shall be maintained by the committee.

���� e.� Each long-term care 
facility shall appoint a consultant pharmacist who is not also the director of 
pharmaceutical services or pharmacist provider, and who attests that he or she 
does not have an affiliation with either the facility�s director of pharmaceutical 
services or the facility�s pharmacist provider.� Following the appointment of 
the consultant pharmacist, the consultant pharmacist shall avoid all real or 
potential conflicts of interest with the facility�s director of pharmaceutical 
services or the facility�s pharmacist provider.

���� f.� If a long-term care 
facility keeps emergency injectable or oral controlled substances, the facility 
shall ensure that a current Drug Enforcement Administration registration and 
controlled dangerous substance registration for that location is available.

���� 2.��� The Commissioner of 
Health, in consultation with the New Jersey 
State Board of Pharmacy, shall adopt rules and regulations, in 
accordance with the �Administrative Procedure Act,� P.L.1968, c.410 (C.52:14B-1 
et seq.), as are necessary to effectuate the provisions of this act.

���� 3.��� This act shall take 
effect immediately. 

STATEMENT

����� This bill codifies current Department of Health 
regulations concerning the provision of pharmaceutical services in long-term 
care facilities, and establishes an additional requirement to aid in preventing 
certain conflicts of interest.

����� Under the bill and current regulations, each 
long-term care facility is to have a consultant pharmacist and either a 
provider pharmacist or, if the facility has an in-house pharmacy, a director of 
pharmaceutical services.� A New Jersey licensed pharmacist is to serve as 
director of pharmaceutical services or as consultant pharmacist.� The 
pharmacist is required to comply with federal and State statutes, rules, 
regulations, and currently accepted standards of practice.

����� The bill and current regulations provide that each 
long-term care facility is to have an interdisciplinary pharmacy and 
therapeutics committee, appointed by and reporting to the administrator of the 
facility and consisting of at least the administrator, a representative of the 
nursing staff, and the facility�s consultant pharmacist, with oversight as 
needed by the facility�s medical director.� The committee may include a 
licensed pharmacist representing the provider pharmacy.� The committee is to 
hold meetings at least quarterly.� Records, including the dates of meetings, 
attendance, activities, findings, and recommendations, are to be maintained by 
the committee.

����� Under the bill and current regulations, the long-term 
care facility is to appoint a consultant pharmacist who is not also the 
director of pharmaceutical services or pharmacist provi